Pathophysiological mechanisms of complications associated with propionic acidemia

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Propionic acidemia (PA) is a genetic metabolic disorder resulting from mutations in propionyl-CoA carboxylase (PCC).
• PA disrupts the conversion of propionyl-CoA to methylmalonyl-CoA, leading to toxic metabolite accumulation.
• This accumulation can cause severe complications, including cardiac disease and metabolic strokes.

Purpose of the Study:

• To review the pathophysiological mechanisms underlying PA-induced complications.
• To highlight current understanding and gaps in knowledge regarding PA pathogenesis.
• To inform the development of novel therapeutic strategies for PA.

Main Methods:

• Literature review of clinical reports and research studies on Propionic Acidemia.
• Analysis of proposed mechanisms involving propionyl-CoA toxicity, oxidative stress, and hyperammonemia.
• Exploration of emerging areas like lipid metabolism and histone modification.

Main Results:

• Propionyl-CoA and its metabolites are implicated in impairing mitochondrial energy metabolism and inducing oxidative stress.
• Elevated ammonia levels contribute to toxicity in some PA patients.
• Evidence for direct in vivo mechanisms of PA-induced cellular damage requires further investigation.

Conclusions:

• Understanding PA's complex pathophysiology is crucial for effective treatment development beyond dietary management.
• Further research into lipid metabolism alterations and histone propionylation is warranted.
• Targeting specific molecular pathways may offer new therapeutic avenues for PA patients.